__timestamp | AbbVie Inc. | Grifols, S.A. |
---|---|---|
Wednesday, January 1, 2014 | 7724000000 | 660772000 |
Thursday, January 1, 2015 | 6387000000 | 736435000 |
Friday, January 1, 2016 | 5855000000 | 775266000 |
Sunday, January 1, 2017 | 6275000000 | 860348000 |
Monday, January 1, 2018 | 7399000000 | 814775000 |
Tuesday, January 1, 2019 | 6942000000 | 942821000 |
Wednesday, January 1, 2020 | 11299000000 | 985616000 |
Friday, January 1, 2021 | 12349000000 | 1061508000 |
Saturday, January 1, 2022 | 15260000000 | 1190423000 |
Sunday, January 1, 2023 | 12872000000 | 1254234000 |
Monday, January 1, 2024 | 14752000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of major players is crucial. AbbVie Inc. and Grifols, S.A., two giants in the sector, have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses over the past decade.
From 2014 to 2023, AbbVie Inc. has seen a significant increase in SG&A expenses, peaking in 2022 with a 97% rise from 2014. This upward trajectory reflects the company's aggressive expansion and marketing strategies.
In contrast, Grifols, S.A. has maintained a more stable SG&A expense pattern, with a modest 90% increase over the same period. This consistency highlights Grifols' focus on operational efficiency and cost management.
These insights offer a glimpse into the strategic priorities of these pharmaceutical leaders, providing valuable lessons for investors and industry analysts alike.
Who Optimizes SG&A Costs Better? AbbVie Inc. or argenx SE
Selling, General, and Administrative Costs: AbbVie Inc. vs Biogen Inc.
AbbVie Inc. or Insmed Incorporated: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Opthea Limited
AbbVie Inc. vs ImmunityBio, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: AbbVie Inc. vs Soleno Therapeutics, Inc.
Who Optimizes SG&A Costs Better? AbbVie Inc. or Mesoblast Limited
Selling, General, and Administrative Costs: Bristol-Myers Squibb Company vs Grifols, S.A.
BioMarin Pharmaceutical Inc. vs Grifols, S.A.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Halozyme Therapeutics, Inc. and Grifols, S.A.
Operational Costs Compared: SG&A Analysis of Grifols, S.A. and MorphoSys AG
Grifols, S.A. and Agios Pharmaceuticals, Inc.: SG&A Spending Patterns Compared